Home › Dementia › Florida › The Villages
Dementia clinical trials in The Villages, FL
6 studies for Dementia are looking for participants at sites in and around The Villages (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
RecruitingPhase 3
- Local Institution - 0129, The Villages
- K2 MEDICAL Research THE VILLAGES, Lady Lake · 3 mi away
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
RecruitingPhase 1
- Charter Research, LLC, The Villages
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RecruitingPhase 3
- Charter Research - Lady Lake, The Villages
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
RecruitingPhase 1/2
- Charter Research, LLC, The Villages
- K2 Medical Research The Villages LLC, Lady Lake · 3 mi away
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
RecruitingPhase 3
- Charter Research - The Villages, The Villages
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
RecruitingPhase 2
- Charter Research The Villages, The Villages
About Dementia
People with dementia have serious problems with two or more brain functions, such as memory and language. Affects the ability to do normal activities.
More about Dementia on MedlinePlus
Dementia trials in other cities
- New York City, NY12 studies
- Los Angeles, CA12 studies
- Chicago, IL10 studies
- Baltimore, MD8 studies
- Durham, NC8 studies
- Tampa, FL8 studies
- Boston, MA8 studies
- Orlando, FL8 studies
- Atlanta, GA8 studies
- Miami, FL8 studies
- Indianapolis, IN8 studies
- St. Louis, MO8 studies
Other studies in The Villages
- Alzheimer's Disease15 studies
- Obesity9 studies
- Overweight8 studies
- Mild Cognitive Impairment4 studies
- Steatotic Liver Disease3 studies
- Parkinson's Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.